Civic Intelligence

Global Solutions for Infectious Diseases

990 • Fiscal year 2024 • EIN 20-0941177

Jan 01, 2024 to Dec 31, 2024 • Filed on Apr 01, 2025

3527 MT Diablo Blvd 478Lafayette, CA 94549

(650) 228-7908

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

56th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2024 filings • 501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

57th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2024 filings • 501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

1st percentile

-1959%

Higher net margin than 1% of similar nonprofits.

2024 filings • 501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

99th percentile

$203,000

Higher top officer pay than 99% of similar nonprofits.

Top officer pay equals 1210.9% of source-year revenue.

2024 filings • 501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

9th percentile

-62%

Faster asset growth than 9% of similar nonprofits.

2024 filings • 501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

2nd percentile

-98%

Faster revenue growth than 2% of similar nonprofits.

2024 filings • 501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Down

$206,881

Down $332,136 (-62%) from 2023

Net Assets

Down

$206,881

Down $328,381 (-61%) from 2023

Liabilities

Down

$0

Down $3,755 (-100%) from 2023

Revenue

Down

$16,765

Down $793,183 (-98%) from 2023

Expenses

Down

$345,146

Down $451,888 (-57%) from 2023

Net Income

Down

-$328,381

Down $341,295 (-2643%) from 2023

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2010: $653,551Liabilities 2010: $61,974Net Assets 2010: $591,5772010Assets 2011: $718,514Liabilities 2011: $64,352Net Assets 2011: $654,1622011Assets 2012: $457,105Liabilities 2012: $37,311Net Assets 2012: $419,7942012Assets 2013: $568,786Liabilities 2013: $38,311Net Assets 2013: $530,4752013Assets 2014: $532,428Liabilities 2014: $48,391Net Assets 2014: $484,0372014Assets 2015: $416,828Liabilities 2015: $40,312Net Assets 2015: $376,5162015Assets 2016: $487,411Liabilities 2016: $39,149Net Assets 2016: $448,2622016Assets 2017: $483,862Liabilities 2017: $8,562Net Assets 2017: $475,3002017Assets 2018: $407,572Liabilities 2018: $9,439Net Assets 2018: $398,1332018Assets 2019: $252,856Liabilities 2019: $7,875Net Assets 2019: $244,9812019Assets 2020: $351,151Liabilities 2020: $8,323Net Assets 2020: $342,8282020Assets 2021: $609,139Liabilities 2021: $5,640Net Assets 2021: $603,4992021Assets 2022: $528,108Liabilities 2022: $5,760Net Assets 2022: $522,3482022Assets 2023: $539,017Liabilities 2023: $3,755Net Assets 2023: $535,2622023Assets 2024: $206,881Liabilities 2024: $0Net Assets 2024: $206,8812024Assets 2025: $0Liabilities 2025: $0Net Assets 2025: $02025

Highlighted filing

2024

Assets$206,881
Liabilities$0
Net Assets$206,881

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2010: $2,184,040Expenses 2010: $2,526,758Net Income 2010: -$342,7182010Revenue 2011: $1,792,208Expenses 2011: $1,729,623Net Income 2011: $62,5852011Expenses 2012: $1,537,1392012Revenue 2013: $1,980,374Expenses 2013: $1,869,693Net Income 2013: $110,6812013Revenue 2014: $1,696,287Expenses 2014: $1,742,725Net Income 2014: -$46,4382014Revenue 2015: $1,657,946Expenses 2015: $1,765,467Net Income 2015: -$107,5212015Revenue 2016: $1,745,170Expenses 2016: $1,673,424Net Income 2016: $71,7462016Revenue 2017: $1,716,690Expenses 2017: $1,689,652Net Income 2017: $27,0382017Revenue 2018: $1,439,966Expenses 2018: $1,517,133Net Income 2018: -$77,1672018Revenue 2019: $926,380Expenses 2019: $1,079,532Net Income 2019: -$153,1522019Revenue 2020: $1,128,778Expenses 2020: $1,038,942Net Income 2020: $89,8362020Revenue 2021: $1,338,688Expenses 2021: $1,059,111Net Income 2021: $279,5772021Revenue 2022: $961,683Expenses 2022: $1,042,834Net Income 2022: -$81,1512022Revenue 2023: $809,948Expenses 2023: $797,034Net Income 2023: $12,9142023Revenue 2024: $16,765Expenses 2024: $345,146Net Income 2024: -$328,3812024Revenue 2025: $1,463Expenses 2025: $101,338Net Income 2025: -$99,8752025

Highlighted filing

2024

Revenue$16,765
Expenses$345,146
Net Income-$328,381
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Apr 1, 2025
Return Version
2024v5.1
Gross Receipts
$16,765
Mission and Program Overview

Mission

The mission of gsid is to expand the development of low-cost effective tools for the diagnosis and prevention of infectious diseases afflicting less developed countries.

SEE SCHEDULE O.

Balance Sheet Detail
LineBeginningEndChange
Assets
Savings and Temporary Cash Investments$500,000$203,163▼ $296,837
Cash and Non-Interest-Bearing Accounts$36,690$3,718▼ $32,972
Accounts Receivable$2,327--
Land, Buildings, and Equipment, Net$0--
Total Assets$539,017$206,881▼ $332,136
Liabilities
Accounts Payable and Accrued Expenses$3,755--
Total Liabilities$3,755$0▼ $3,755
Net Assets / Fund Balance
Net Assets With Donor Restrictions$535,262$206,881▼ $328,381
Total Net Assets Fund Balance$535,262$206,881▼ $328,381
Total Liabilities and Net Assets / Fund Balance$539,017$206,881▼ $332,136
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Carter a LeeExecutive DirectorPT$123,000$80,000$203,000
Dr Seung-il ShinBoard Member-$20,000-$20,000

Board Members and Trustees

NameTitle
Faruk M SinangilBoard Member/director Research Collaborations
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$0
Investment Income
$16,765
Other Revenue
$0
Change in Net Assets
$-328,381
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$303,077
Other Expenses$42,069
Total Fundraising Expense$30,308
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$178,400$22,300$22,300$223,000
Other Salaries and Wages$48,000$6,000$6,000$60,000
Pension Plan Contributions$16,061$2,008$2,008$20,077
Fees for Services Accounting-$19,527-$19,527
Office Expenses-$602-$602
Other Expenses$2,255$352-$352
Information Technology-$160-$160
Total Functional Expenses$263,889$50,949$30,308$345,146
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

Prior to filing, a complete copy of the final form 990 was distributed to all voting board members who reviewed and discussed the return. The discussion was formalized in the board minutes and a resolution was proposed and voted upon to document the review and give authorization to the executive director to file the return with the internal revenue service.

Form 990, Part VI, Section B, Line 12C

The board is charged with monitoring proposed or ongoing transactions for conflicts of interest and addressing any potential or actual conflicts. Pursuant to the conflict of interest policy, an annual conflict of interest questionnaire, aimed at determining any family and business relationships and transactions or other transactions that may pose a potential conflict, is distributed to all covered persons (i.e., board members, officers and executive leadership or key employees). Covered persons are required to disclose real or potential conflicts at the time when such conflicts arise. When someone becomes a covered person and annually thereafter, each covered person is required to sign a statement affirming that he/she: (1) has received a copy of the conflict of interest policy; (2) has read the policy and understands said policy; and (3) agrees to comply with all requirements of the policy, including completing the conflict of interest questionnaire. The completed questionnaires are reviewed by the board and any persons with actual or potential conflicts are informed via written communication. The procedures for addressing any conflict of interest includes, but is not limited to, the following: (1) the conflicting interest is fully disclosed to the board; (2) the interested person responds to factual questions related to the substance of the transaction or arrangement being considered, after which he/she shall leave the meeting; (3) the person with the conflict of interest is excluded from the discussion and approval of such transaction; (4) alternatives to the proposed transaction are investigated, competitive bids or comparable valuations are obtained; and (5) the transaction or action must be approved by a majority of disinterested persons.

Form 990, Part VI, Section B, Line 15

Compensation of the organization two officers is decided upon and approved global solutions for infectious diseases (20-0941177) by the board of directors. The board utilizes industry data to determine salary levels and increases. Because the organization's two internal directors are also active officers, the director cannot approve his salary and therefore must recuse himself from the board action. The external board member is always included in the compensation approval process.

Form 990, Part VI, Section C, Line 18

Gsid makes its financial information available on request only and on websites such as guidestar.

Form 990, Part VI, Section C, Line 19

Gsid makes its financial information available on request only and on websites such as guidestar.

FORM 990, PART VI, LINE 13:

Gsid is a scientifically-based organization which encourages open communication and the exchange of ideas and opinions. Because it is a small organization, it does not believe it is necessary to implement a formal whistleblower policy.

Filing and Contact Details

Filer

Filer Name
Global Solutions for Infectious Diseases
EIN
20-0941177
Phone
6502287908
Address
3527 MT DIABLO BLVD 478, LAFAYETTE, CA 94549

Signing Officer

Name
Carter a Lee
Title
Exec Director
Phone
6502287908
Signed
2025-04-01
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Carter a Lee
Formed
2004
Legal Domicile
CA
Voting Board Members
3
Independent Board Members
1
Employees
5
Volunteers
1

Preparer

Firm
Kpmg Llp
Address
550 S HOPE STREET STE 1500, LOS ANGELES, CA 90071
Preparer
David M Highfill
Phone
2139724000
Supplemental Narrative

Additional Explanations

FORM 990, PART I, LINE 1:

The mission of gsid is to expand the development of low-cost effective tools for the diagnosis and prevention of infectious diseases afflicting less developed countries.

FORM 990, PART III, LINE 1:

The specific and primary purpose and charitable mission of global solutions for infectious diseases is to conduct research on and develop vaccines and diagnostics for life-threatening infectious diseases, including hiv. Gsid is also committed to provide assistance to and collaborate with other global public health organizations, private foundations, and for-profit entities focused on public health issues, for the purpose of facilitating access to affordable health solutions which benefit the people in developing countries, who are the most in need.

Raw XML Appendix337 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt03755
IRS990/AccountsReceivableGrp/BOYAmt02327
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SEE SCHEDULE O.
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0CARTER A LEE
IRS990/BooksInCareOfDetail/PhoneNum06502287908
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03527 MT DIABLO BLVD 478
IRS990/BooksInCareOfDetail/USAddress/CityNm0LAFAYETTE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094549
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt036690
IRS990/CashNonInterestBearingGrp/EOYAmt03718
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt022300
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt022300
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0178400
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0223000
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt016765
IRS990/CYOtherExpensesAmt042069
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-328381
IRS990/CYSalariesCompEmpBnftPaidAmt0303077
IRS990/CYTotalExpensesAmt0345146
IRS990/CYTotalFundraisingExpenseAmt030308
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt016765
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0AIDSVAX HIV VACCINE PROGRAM:GSID'S ONLY PROGRAM SERVICE AREA IN 2024 WAS SERVING AS MANUFACTURING AND PRODUCT SPONSOR FOR ITS AIDSVAX VACCINE AND MAINTAINING A MANUFACTURING REAGENTS REPOSITORY AND CLINICAL TRIAL (PREVIOUSLY CONDUCTED) DATABASES. SINCE 2020, THE VACCINE HAS BEEN EVALUATED IN AN ONGOING PHASE 2B CLINICAL TRIAL CENTERED IN THREE SUB-SAHARAN AFRICAN COUNTRIES. FUNDING FOR GSID'S ACTIVITIES IN PRIOR YEARS WAS PROVIDED BY THE HENRY M. JACKSON FOUNDATION (BETHESDA, MD) AND THE IMPERIAL COLLEGE, LONDON (UNITED KINGDOM), THE SPONSOR OF THE AFORMENTIONED CLINICAL TRIAL.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0535262
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0206881
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0263889
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt019527
IRS990/FeesForServicesAccountingGrp/TotalAmt019527
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt020.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0CARTER A LEE
IRS990/Form990PartVIISectionAGrp/PersonNm1FARUK M SINANGIL
IRS990/Form990PartVIISectionAGrp/PersonNm2DR SEUNG-IL SHIN
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0203000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt220000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1BOARD MEMBER/DIRECTOR RESEARCH COLLABORATIONS
IRS990/Form990PartVIISectionAGrp/TitleTxt2BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt016765
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt01
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt0160
IRS990/InformationTechnologyGrp/TotalAmt0160
IRS990/InvestmentIncomeGrp/ExclusionAmt016765
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt016765
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipBasisNetGrp/BOYAmt00
IRS990/LandBldgEquipCostOrOtherBssAmt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0SEE SCHEDULE O.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0535262
IRS990/NetAssetsOrFundBalancesEOYAmt0206881
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0602
IRS990/OfficeExpensesGrp/TotalAmt0602
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0VACCINE STORAGE & DIST.
IRS990/OtherExpensesGrp/Desc1OFFSITE DOC. STORAGE
IRS990/OtherExpensesGrp/Desc2SUPPLIES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0352
IRS990/OtherExpensesGrp/ProgramServicesAmt019173
IRS990/OtherExpensesGrp/ProgramServicesAmt12255
IRS990/OtherExpensesGrp/TotalAmt019173
IRS990/OtherExpensesGrp/TotalAmt12255
IRS990/OtherExpensesGrp/TotalAmt2352
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt06000
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt06000
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt048000
IRS990/OtherSalariesAndWagesGrp/TotalAmt060000
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PensionPlanContributionsGrp/FundraisingAmt02008
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt02008
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt016061
IRS990/PensionPlanContributionsGrp/TotalAmt020077
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0CARTER A LEE
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0804718
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt05230
IRS990/PYOtherExpensesAmt0235353
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt012914
IRS990/PYSalariesCompEmpBnftPaidAmt0561681
IRS990/PYTotalExpensesAmt0797034
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0809948
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-328381
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0500000
IRS990/SavingsAndTempCashInvstGrp/EOYAmt0203163
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt00
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0804718
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0961139
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01388688
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01128778
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt04283323
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.88340
IRS990ScheduleA/PublicSupportPY170Pct00.90770
IRS990ScheduleA/PublicSupportTotal170Amt03783989
IRS990ScheduleA/SubstantialContributorsTotAmt0499334
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0804718
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0961139
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01388688
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01128778
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt04283323
IRS990ScheduleA/TotalSupportAmt04283323
IRS990/ScheduleBRequiredInd00
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0123000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount080000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm0CARTER A LEE
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt0EXECUTIVE DIRECTOR
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt0203000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt00
IRS990ScheduleJ/SeverancePaymentInd00
IRS990ScheduleJ/SupplementalNonqualRtrPlanInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE MISSION OF GSID IS TO EXPAND THE DEVELOPMENT OF LOW-COST EFFECTIVE TOOLS FOR THE DIAGNOSIS AND PREVENTION OF INFECTIOUS DISEASES AFFLICTING LESS DEVELOPED COUNTRIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE SPECIFIC AND PRIMARY PURPOSE AND CHARITABLE MISSION OF GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES IS TO CONDUCT RESEARCH ON AND DEVELOP VACCINES AND DIAGNOSTICS FOR LIFE-THREATENING INFECTIOUS DISEASES, INCLUDING HIV. GSID IS ALSO COMMITTED TO PROVIDE ASSISTANCE TO AND COLLABORATE WITH OTHER GLOBAL PUBLIC HEALTH ORGANIZATIONS, PRIVATE FOUNDATIONS, AND FOR-PROFIT ENTITIES FOCUSED ON PUBLIC HEALTH ISSUES, FOR THE PURPOSE OF FACILITATING ACCESS TO AFFORDABLE HEALTH SOLUTIONS WHICH BENEFIT THE PEOPLE IN DEVELOPING COUNTRIES, WHO ARE THE MOST IN NEED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2PRIOR TO FILING, A COMPLETE COPY OF THE FINAL FORM 990 WAS DISTRIBUTED TO ALL VOTING BOARD MEMBERS WHO REVIEWED AND DISCUSSED THE RETURN. THE DISCUSSION WAS FORMALIZED IN THE BOARD MINUTES AND A RESOLUTION WAS PROPOSED AND VOTED UPON TO DOCUMENT THE REVIEW AND GIVE AUTHORIZATION TO THE EXECUTIVE DIRECTOR TO FILE THE RETURN WITH THE INTERNAL REVENUE SERVICE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE BOARD IS CHARGED WITH MONITORING PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND ADDRESSING ANY POTENTIAL OR ACTUAL CONFLICTS. PURSUANT TO THE CONFLICT OF INTEREST POLICY, AN ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE, AIMED AT DETERMINING ANY FAMILY AND BUSINESS RELATIONSHIPS AND TRANSACTIONS OR OTHER TRANSACTIONS THAT MAY POSE A POTENTIAL CONFLICT, IS DISTRIBUTED TO ALL COVERED PERSONS (I.E., BOARD MEMBERS, OFFICERS AND EXECUTIVE LEADERSHIP OR KEY EMPLOYEES). COVERED PERSONS ARE REQUIRED TO DISCLOSE REAL OR POTENTIAL CONFLICTS AT THE TIME WHEN SUCH CONFLICTS ARISE. WHEN SOMEONE BECOMES A COVERED PERSON AND ANNUALLY THEREAFTER, EACH COVERED PERSON IS REQUIRED TO SIGN A STATEMENT AFFIRMING THAT HE/SHE: (1) HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY; (2) HAS READ THE POLICY AND UNDERSTANDS SAID POLICY; AND (3) AGREES TO COMPLY WITH ALL REQUIREMENTS OF THE POLICY, INCLUDING COMPLETING THE CONFLICT OF INTEREST QUESTIONNAIRE. THE COMPLETED QUESTIONNAIRES ARE REVIEWED BY THE BOARD AND ANY PERSONS WITH ACTUAL OR POTENTIAL CONFLICTS ARE INFORMED VIA WRITTEN COMMUNICATION. THE PROCEDURES FOR ADDRESSING ANY CONFLICT OF INTEREST INCLUDES, BUT IS NOT LIMITED TO, THE FOLLOWING: (1) THE CONFLICTING INTEREST IS FULLY DISCLOSED TO THE BOARD; (2) THE INTERESTED PERSON RESPONDS TO FACTUAL QUESTIONS RELATED TO THE SUBSTANCE OF THE TRANSACTION OR ARRANGEMENT BEING CONSIDERED, AFTER WHICH HE/SHE SHALL LEAVE THE MEETING; (3) THE PERSON WITH THE CONFLICT OF INTEREST IS EXCLUDED FROM THE DISCUSSION AND APPROVAL OF SUCH TRANSACTION; (4) ALTERNATIVES TO THE PROPOSED TRANSACTION ARE INVESTIGATED, COMPETITIVE BIDS OR COMPARABLE VALUATIONS ARE OBTAINED; AND (5) THE TRANSACTION OR ACTION MUST BE APPROVED BY A MAJORITY OF DISINTERESTED PERSONS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4COMPENSATION OF THE ORGANIZATION TWO OFFICERS IS DECIDED UPON AND APPROVED GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES (20-0941177) BY THE BOARD OF DIRECTORS. THE BOARD UTILIZES INDUSTRY DATA TO DETERMINE SALARY LEVELS AND INCREASES. BECAUSE THE ORGANIZATION'S TWO INTERNAL DIRECTORS ARE ALSO ACTIVE OFFICERS, THE DIRECTOR CANNOT APPROVE HIS SALARY AND THEREFORE MUST RECUSE HIMSELF FROM THE BOARD ACTION. THE EXTERNAL BOARD MEMBER IS ALWAYS INCLUDED IN THE COMPENSATION APPROVAL PROCESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5GSID MAKES ITS FINANCIAL INFORMATION AVAILABLE ON REQUEST ONLY AND ON WEBSITES SUCH AS GUIDESTAR.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6GSID MAKES ITS FINANCIAL INFORMATION AVAILABLE ON REQUEST ONLY AND ON WEBSITES SUCH AS GUIDESTAR.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7GSID IS A SCIENTIFICALLY-BASED ORGANIZATION WHICH ENCOURAGES OPEN COMMUNICATION AND THE EXCHANGE OF IDEAS AND OPINIONS. BECAUSE IT IS A SMALL ORGANIZATION, IT DOES NOT BELIEVE IT IS NECESSARY TO IMPLEMENT A FORMAL WHISTLEBLOWER POLICY.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART I, LINE 1:
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART III, LINE 1:
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 18
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7FORM 990, PART VI, LINE 13:
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0539017
IRS990/TotalAssetsEOYAmt0206881
IRS990/TotalAssetsGrp/BOYAmt0539017
IRS990/TotalAssetsGrp/EOYAmt0206881
IRS990/TotalCompGreaterThan150KInd01
IRS990/TotalEmployeeCnt05
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt030308
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt050949
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0263889
IRS990/TotalFunctionalExpensesGrp/TotalAmt0345146
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt03755
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt03755
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0535262
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0206881
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0263889
IRS990/TotalReportableCompFromOrgAmt0223000
IRS990/TotalRevenueGrp/ExclusionAmt016765
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt016765
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt01
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0539017
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0206881
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt03527 MT DIABLO BLVD 478
IRS990/USAddress/CityNm0LAFAYETTE
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd094549
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt01
IRS990/WebsiteAddressTxt0WWW.GSID.ORG
IRS990/WhistleblowerPolicyInd00
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0CARTER A LEE
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXEC DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum06502287908
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-04-01
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0GLOBAL SOLUTIONS FOR INFECTIOUS DISEASES
ReturnHeader/Filer/BusinessNameControlTxt0GLOB
ReturnHeader/Filer/EIN0200941177
ReturnHeader/Filer/PhoneNum06502287908
ReturnHeader/Filer/USAddress/AddressLine1Txt03527 MT DIABLO BLVD 478
ReturnHeader/Filer/USAddress/CityNm0LAFAYETTE
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094549
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0135565207
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0KPMG LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0550 S HOPE STREET STE 1500
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0LOS ANGELES
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd090071
ReturnHeader/PreparerPersonGrp/PhoneNum02139724000
ReturnHeader/PreparerPersonGrp/PreparationDt02025-03-06
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DAVID M HIGHFILL
ReturnHeader/ReturnTs02025-04-09T15:52:07-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$0.00$0.00$0.00$0.00$0.10$0.10
2024Detailed filing. Detailed filing data is available for this year.$0.21$0.00$0.21$0.02$0.35$0.33
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.54$0.00$0.54$0.81$0.80$0.01
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.53$0.01$0.52$0.96$1.04$0.08
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.61$0.01$0.60$1.34$1.06$0.28
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.35$0.01$0.34$1.13$1.04$0.09
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.25$0.01$0.24$0.93$1.08$0.15
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.41$0.01$0.40$1.44$1.52$0.08
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.48$0.01$0.48$1.72$1.69$0.03
2016Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.49$0.04$0.45$1.75$1.67$0.07
2015XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.42$0.04$0.38$1.66$1.77$0.11
2014Detailed filing. Detailed filing data is available for this year.$0.53$0.05$0.48$1.70$1.74$0.05
2013Detailed filing. Detailed filing data is available for this year.$0.57$0.04$0.53$1.98$1.87$0.11
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.04$0.42$1.54
2011Summary only. Only limited summary data is available for this year.$0.72$0.06$0.65$1.79$1.73$0.06
2010Summary only. Only limited summary data is available for this year.$0.65$0.06$0.59$2.18$2.53$0.34